Drug Type Synthetic peptide |
Synonyms BI 473494 |
Target |
Action agonists |
Mechanism AMYR agonists(Amylin receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Phase 1 | - | - | |
Diabetes Mellitus | Phase 1 | - | - | |
Obesity | Phase 1 | Germany | - | |
Obesity | Phase 1 | - | - | |
Obesity | Phase 1 | - | - |
Phase 1 | - | 16 | (BI 473494 35 μg) | lqokccqhzt = cdpefbxywq rrtysopwou (fyhfmlwyix, zutfqfrwka - szqlueifrm) View more | - | 22 Jun 2022 | |
(BI 473494 75 μg) | lqokccqhzt = iqycikuxkw rrtysopwou (fyhfmlwyix, mptzucuthy - ksrvmujdeb) View more |